Skip to main content
Top
Published in: AIDS and Behavior 3/2005

01-09-2005 | BEHAVIORAL CHANGES IN THE ERA OF COMBINATION THERAPIES

Sexual Risk Behavior Among Injection Drug Users Before Widespread Availability of Highly Active Antiretroviral Therapy

Authors: Melanie L. Rusch, Homayoon Farzadegan, Patrick M. Tarwater, Mahboobeh Safaeian, David Vlahov, Steffanie A. Strathdee

Published in: AIDS and Behavior | Issue 3/2005

Login to get access

Abstract

HIV testing and counseling has been associated with reductions in risk behaviors in some populations. This study examined whether involvement in a long-term study, including exposure to repeated HIV testing and counseling, was associated with increased condom use among injection drug users (IDUs) through a retrospective analysis of an IDU cohort from Baltimore, MD, during 1994–1998. Eligibility included being aged 18 years or older, injecting within 10 years and not having initiated antiretroviral therapy. A logistic model of high versus low risk, based on condom use, was used. Of 322 eligible IDUs, most were male (66%) and African-American (94%). No significant change in the odds of inconsistent condom use was observed with continued study exposure. Condom use remained low, indicating a need for interventions to reduce sexual risks and HIV transmission in this population.
Literature
go back to reference Bruneau, J., Lamothe, F., Soto, J., Lachance, N., Vincelette, J., Vassal, A., and Franco, E. L. (2001). Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal, 164, 767–773.PubMed Bruneau, J., Lamothe, F., Soto, J., Lachance, N., Vincelette, J., Vassal, A., and Franco, E. L. (2001). Sex-specific determinants of HIV infection among injection drug users in Montreal. Canadian Medical Association Journal, 164, 767–773.PubMed
go back to reference Colfax, G. N., Buchbinder, S. P., Cornelisse, P. G. A., Vittinghoff, E., Mayer, K., and Celum, C. (2002). Sexual risk behaviours and implications for secondary HIV transmission during and after HIV seroconversion. AIDS, 16, 1529–1535.CrossRefPubMed Colfax, G. N., Buchbinder, S. P., Cornelisse, P. G. A., Vittinghoff, E., Mayer, K., and Celum, C. (2002). Sexual risk behaviours and implications for secondary HIV transmission during and after HIV seroconversion. AIDS, 16, 1529–1535.CrossRefPubMed
go back to reference Diggle, P. J., Liang, K., and Zeger, S. L. (1995). Analysis of longitudinal data. (2nd ed.) New York: Oxford University Press. Diggle, P. J., Liang, K., and Zeger, S. L. (1995). Analysis of longitudinal data. (2nd ed.) New York: Oxford University Press.
go back to reference Dolezal, C., Meyer-Bahlburg, H. F. L., Liu, X., Ehrhardt, A. A., Exner, T. M., Rabkin, J. G., Gorman, J. M., Marder, K., and Stern, Y. (1999). Longitudinal changes in sexual risk behaviour among HIV+ and HIV− male injecting drug users. American Journal of Drug and Alcohol Abuse, 25, 281–303.CrossRefPubMed Dolezal, C., Meyer-Bahlburg, H. F. L., Liu, X., Ehrhardt, A. A., Exner, T. M., Rabkin, J. G., Gorman, J. M., Marder, K., and Stern, Y. (1999). Longitudinal changes in sexual risk behaviour among HIV+ and HIV− male injecting drug users. American Journal of Drug and Alcohol Abuse, 25, 281–303.CrossRefPubMed
go back to reference Donoghoe, M. C. (1992). Sex, HIV and the injecting drug users. British Journal of Addiction, 87, 405–416.PubMedCrossRef Donoghoe, M. C. (1992). Sex, HIV and the injecting drug users. British Journal of Addiction, 87, 405–416.PubMedCrossRef
go back to reference Dukers, N., Goudsmit, J., de Wit, J. B. F., Prins, M., Weverling, G., and Coutinho, R. A. (2001). Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS, 15, 369–378.CrossRefPubMed Dukers, N., Goudsmit, J., de Wit, J. B. F., Prins, M., Weverling, G., and Coutinho, R. A. (2001). Sexual risk behaviour relates to the virological and immunological improvements during highly active antiretroviral therapy in HIV-1 infection. AIDS, 15, 369–378.CrossRefPubMed
go back to reference Dwyer, R., Richardson, D., Ross, M. W., Wodak, A., Miller, M. E., and Gold, J. (1994). A Comparison of HIV risk between women and men who inject drugs. AIDS Education and Prevention, 6, 379–389.PubMed Dwyer, R., Richardson, D., Ross, M. W., Wodak, A., Miller, M. E., and Gold, J. (1994). A Comparison of HIV risk between women and men who inject drugs. AIDS Education and Prevention, 6, 379–389.PubMed
go back to reference Erbelding, E. J., Stanton, D., Quinn, T. C., and Rompalo, A. (2000). Behavioural and biological evidence of persistent high-risk behaviour in an HIV primary care population. AIDS, 14, 297–301.CrossRefPubMed Erbelding, E. J., Stanton, D., Quinn, T. C., and Rompalo, A. (2000). Behavioural and biological evidence of persistent high-risk behaviour in an HIV primary care population. AIDS, 14, 297–301.CrossRefPubMed
go back to reference Jivasak-Apimas, S., Saba, J., Chandeying, V., Sakondhavat, C., Kiriwat, O., Rugpao, S., Rojanapithayakorn, W., and Fontanet, A. (2001). Acceptability of the female condom among sex workers in Thailand. Sexually Transmitted Diseases, 28, 648–654.CrossRefPubMed Jivasak-Apimas, S., Saba, J., Chandeying, V., Sakondhavat, C., Kiriwat, O., Rugpao, S., Rojanapithayakorn, W., and Fontanet, A. (2001). Acceptability of the female condom among sex workers in Thailand. Sexually Transmitted Diseases, 28, 648–654.CrossRefPubMed
go back to reference Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., and Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk factor analysis. The Lancet, 357, 1397–1401. Kral, A. H., Bluthenthal, R. N., Lorvick, J., Gee, L., Bacchetti, P., and Edlin, B. R. (2001). Sexual transmission of HIV-1 among injection drug users in San Francisco, USA: Risk factor analysis. The Lancet, 357, 1397–1401.
go back to reference Macalino, G. E., Celentano, D. D., Latkin, C. A., Strathdee, S. A., and Vlahov, D. (2002). Risk behaviours by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention, 14, 367–378.CrossRefPubMed Macalino, G. E., Celentano, D. D., Latkin, C. A., Strathdee, S. A., and Vlahov, D. (2002). Risk behaviours by audio computer-assisted self-interviews among HIV-seropositive and HIV-seronegative injection drug users. AIDS Education and Prevention, 14, 367–378.CrossRefPubMed
go back to reference Maxwell, C., and Boyle, M. (1995). Risky heterosexual practices amongst women over 30: Gender, power and long term relationships. AIDS Care, 7, 277–293.CrossRefPubMed Maxwell, C., and Boyle, M. (1995). Risky heterosexual practices amongst women over 30: Gender, power and long term relationships. AIDS Care, 7, 277–293.CrossRefPubMed
go back to reference Metzger, D. S., and Navaline, H. (2003). HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health, 80(4, Suppl 3), iii59–iii66.PubMed Metzger, D. S., and Navaline, H. (2003). HIV prevention among injection drug users: The need for integrated models. Journal of Urban Health, 80(4, Suppl 3), iii59–iii66.PubMed
go back to reference Miller, C., Spittal, P. M., LaLiberte, N., Li, K., Tyndall, M., O'Shaughnessy, M., and Schechter, M. T. (2002). Females experiencing sexual and drug vulnerabilities are at elevated risk for hiv infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndrome, 30, 335–341. Miller, C., Spittal, P. M., LaLiberte, N., Li, K., Tyndall, M., O'Shaughnessy, M., and Schechter, M. T. (2002). Females experiencing sexual and drug vulnerabilities are at elevated risk for hiv infection among youth who use injection drugs. Journal of Acquired Immune Deficiency Syndrome, 30, 335–341.
go back to reference Mize, S. J. S., Robinson, B. E., Bockting, W. O., and Scheltema, K. E. (2002). Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care, 14, 163–180.CrossRefPubMed Mize, S. J. S., Robinson, B. E., Bockting, W. O., and Scheltema, K. E. (2002). Meta-analysis of the effectiveness of HIV prevention interventions for women. AIDS Care, 14, 163–180.CrossRefPubMed
go back to reference Nelson, K. E., Galai, N., Safaiean, M., Strathdee, S. A., Celentano, D. D., and Vlahov, D. (2002). Temporal trends in the incidence of human immunodeficiency virus and risk behaviour among injection drug users in Baltimore, Maryland, 1988–1998. American Journal of Epidemiology, 156, 641–653.CrossRefPubMed Nelson, K. E., Galai, N., Safaiean, M., Strathdee, S. A., Celentano, D. D., and Vlahov, D. (2002). Temporal trends in the incidence of human immunodeficiency virus and risk behaviour among injection drug users in Baltimore, Maryland, 1988–1998. American Journal of Epidemiology, 156, 641–653.CrossRefPubMed
go back to reference Rhodes, F., Corby, N. H., Wolitski, R. J., Tashima, N., Crain, C., Yankovich, D. R., and Smith, P. K. (1990). Risk behaviors and perceptions of AIDS among street injection drug users. Journal of Drug Education, 20, 271–288.PubMed Rhodes, F., Corby, N. H., Wolitski, R. J., Tashima, N., Crain, C., Yankovich, D. R., and Smith, P. K. (1990). Risk behaviors and perceptions of AIDS among street injection drug users. Journal of Drug Education, 20, 271–288.PubMed
go back to reference Rietmeijer, C. A., Kane, M. S., Simons, P. Z., Corby, N. H., Wolitski, R. J., Higgins, D. L., Judson, F. N., and Cohn, D. L. (1996). Increasing the use of bleach and condoms among injecting drug users in Denver: Outcomes of a targeted, community-level HIV prevention program. AIDS, 10, 291–298.PubMedCrossRef Rietmeijer, C. A., Kane, M. S., Simons, P. Z., Corby, N. H., Wolitski, R. J., Higgins, D. L., Judson, F. N., and Cohn, D. L. (1996). Increasing the use of bleach and condoms among injecting drug users in Denver: Outcomes of a targeted, community-level HIV prevention program. AIDS, 10, 291–298.PubMedCrossRef
go back to reference Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Flores, S. A., Norman, L., Sweat, M. D., and Needle, R. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviours of drug users in the United States. Journal of Acquired Immune Deficiency Syndrome, 30, S73–S93.CrossRef Semaan, S., Des Jarlais, D. C., Sogolow, E., Johnson, W. D., Hedges, L. V., Ramirez, G., Flores, S. A., Norman, L., Sweat, M. D., and Needle, R. (2002). A meta-analysis of the effect of HIV prevention interventions on the sex behaviours of drug users in the United States. Journal of Acquired Immune Deficiency Syndrome, 30, S73–S93.CrossRef
go back to reference Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Ksobiech, K., and Hackl, K. L. (2003). Predictors of HIV sexual risk behaviors in a community sample of injections drug-using men and women. AIDS and Behavior, 7, 383–393.CrossRefPubMed Somlai, A. M., Kelly, J. A., McAuliffe, T. L., Ksobiech, K., and Hackl, K. L. (2003). Predictors of HIV sexual risk behaviors in a community sample of injections drug-using men and women. AIDS and Behavior, 7, 383–393.CrossRefPubMed
go back to reference Spittal, P. M., Craib, K. J. P., Wood, E., LaLiberte, N., Li, K., Tyndall, M., O'Shaughnessy, M., and Schechter, M. T. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal, 166, 891–899. Spittal, P. M., Craib, K. J. P., Wood, E., LaLiberte, N., Li, K., Tyndall, M., O'Shaughnessy, M., and Schechter, M. T. (2002). Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. Canadian Medical Association Journal, 166, 891–899.
go back to reference Sterk, C. E., Theall, K. P., Elifson, K. W., and Kidder, D. (2003). HIV risk reduction among African-American women who inject drugs: A randomized controlled trial. AIDS and Behavior, 7, 73–86.CrossRefPubMed Sterk, C. E., Theall, K. P., Elifson, K. W., and Kidder, D. (2003). HIV risk reduction among African-American women who inject drugs: A randomized controlled trial. AIDS and Behavior, 7, 73–86.CrossRefPubMed
go back to reference Strathdee, S. A., Celentano, D. D., Shah, N. G., Lyles, C., Stambolis, V. A., Macalino, G. E., Nelson, K. E., and Vlahov, D. (1999). Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health, 76, 448–460.PubMedCrossRef Strathdee, S. A., Celentano, D. D., Shah, N. G., Lyles, C., Stambolis, V. A., Macalino, G. E., Nelson, K. E., and Vlahov, D. (1999). Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health, 76, 448–460.PubMedCrossRef
go back to reference Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., and Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users. Archives of Internal Medicine, 161, 1281–1288.CrossRefPubMed Strathdee, S. A., Galai, N., Safaiean, M., Celentano, D. D., Vlahov, D., Johnson, L., and Nelson, K. E. (2001). Sex differences in risk factors for HIV seroconversion among injection drug users. Archives of Internal Medicine, 161, 1281–1288.CrossRefPubMed
go back to reference Strathdee, S. A., and Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80(4, Suppl 3):iii7–iii14.PubMed Strathdee, S. A., and Sherman, S. G. (2003). The role of sexual transmission of HIV infection among injection and non-injection drug users. Journal of Urban Health, 80(4, Suppl 3):iii7–iii14.PubMed
go back to reference Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS, 17, 1953–1962.CrossRefPubMed Tun, W., Celentano, D. D., Vlahov, D., and Strathdee, S. A. (2003). Attitudes toward HIV treatments influence unsafe sexual and injection practices among injecting drug users. AIDS, 17, 1953–1962.CrossRefPubMed
go back to reference Tun, W., Gange, S. J., Vlahov, D., Strathdee, S. A., and Celentano, D. D. (2004). Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Diseases, 38, 1167–1174.CrossRefPubMed Tun, W., Gange, S. J., Vlahov, D., Strathdee, S. A., and Celentano, D. D. (2004). Increase in sexual risk behavior associated with immunologic response to highly active antiretroviral therapy among HIV-infected injection drug users. Clinical Infectious Diseases, 38, 1167–1174.CrossRefPubMed
go back to reference Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., and Polk, B. F. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Research Monographs, 109, 75–100. Vlahov, D., Anthony, J. C., Munoz, A., Margolick, J., Nelson, K. E., Celentano, D. D., Solomon, L., and Polk, B. F. (1991). The ALIVE study, a longitudinal study of HIV-1 infection in intravenous drug users: Description of methods and characteristics of participants. NIDA Research Monographs, 109, 75–100.
go back to reference Vlahov, D., Safaien, M., Lai, S., Strathdee, S. A., Johnson, L., Sterling, T., and Celentano, D. D. (2001). Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS, 15, 2311–2316.CrossRefPubMed Vlahov, D., Safaien, M., Lai, S., Strathdee, S. A., Johnson, L., Sterling, T., and Celentano, D. D. (2001). Sexual and drug risk-related behaviours after initiating highly active antiretroviral therapy among injection drug users. AIDS, 15, 2311–2316.CrossRefPubMed
go back to reference Watters, J. K. (1994). Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986–1992. Journal of Acquired Immune Deficiency Syndrome, 7, 1276–1281.CrossRef Watters, J. K. (1994). Trends in risk behavior and HIV seroprevalence in heterosexual injection drug users in San Francisco, 1986–1992. Journal of Acquired Immune Deficiency Syndrome, 7, 1276–1281.CrossRef
go back to reference Wingood, G. M., and DiClemente, R. J. (1998). The influence of psychosocial factors, alcohol, drug use on African-American women's high-risk sexual behavior. American Journal of Preventive Medicine, 15, 54–59.CrossRefPubMed Wingood, G. M., and DiClemente, R. J. (1998). The influence of psychosocial factors, alcohol, drug use on African-American women's high-risk sexual behavior. American Journal of Preventive Medicine, 15, 54–59.CrossRefPubMed
go back to reference Witte, S.S., Wada, T., El-Bassel, N., Gilbert, L. and Wallace, J. (2000). Predictors of female condom use among women exchanging street sex in New York city. Sexually Transmitted Diseases, 27, 93–100. Witte, S.S., Wada, T., El-Bassel, N., Gilbert, L. and Wallace, J. (2000). Predictors of female condom use among women exchanging street sex in New York city. Sexually Transmitted Diseases, 27, 93–100.
Metadata
Title
Sexual Risk Behavior Among Injection Drug Users Before Widespread Availability of Highly Active Antiretroviral Therapy
Authors
Melanie L. Rusch
Homayoon Farzadegan
Patrick M. Tarwater
Mahboobeh Safaeian
David Vlahov
Steffanie A. Strathdee
Publication date
01-09-2005
Publisher
Springer US
Published in
AIDS and Behavior / Issue 3/2005
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-005-9003-4

Other articles of this Issue 3/2005

AIDS and Behavior 3/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.